ALEKSANDRA ZAGORIN: Open Payments
NPI 1316909195 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,143 in 10 payments from 8 companies in 2025. Trend: 2023 $745 · 2024 $952 · 2025 $1,143
Food & beverage: $1,143
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $275 |
| Inspire Medical Systems, Inc. | 1 | $147 |
| GlaxoSmithKline, LLC. | 2 | $141 |
| E.R. Squibb & Sons, L.L.C. | 1 | $127 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $124 |
| Teva Pharmaceuticals USA, Inc. | 1 | $121 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $83 |
Products named: REXULTI, INSPIRE, SHINGRIX, COBENFY, DUPIXENT, CAPLYTA, AUSTEDO XR.
Industry payments across NY — which companies pay providers there.
